无症状与有症状孤立性肠系膜动脉夹层的中期结局
单中心回顾性研究纳入2017年1月至2025年8月39例孤立性肠系膜上动脉或腹腔动脉夹层患者,按有无症状分组。有症状者更年轻、白细胞更高、壁内血肿更常见,手术者均为有症状者;两组3年生存率无差异,Zerbib V-VI型与需手术干预相关。
要点
- 无症状孤立性肠系膜动脉夹层可安全采用观察或药物治疗。
- 有症状者中58%无需手术,无急性肠系膜缺血、破裂或血流动力学不稳定者可非手术治疗。
- Zerbib V-VI型和壁内血肿与需手术干预相关。
核心结论
- 无症状与有症状孤立性肠系膜动脉夹层中期结局总体良好。
- 症状、Zerbib V-VI型和壁内血肿与需手术干预的可能性强烈相关。
研究设计与样本
- 单中心回顾性综述,纳入2017年1月至2025年8月孤立性肠系膜上动脉或腹腔动脉夹层患者,排除合并主动脉夹层者。
- 共39例患者,中位年龄58岁(四分位距52-71),男性87%,亚洲人62%。
主要发现
- 肠系膜上动脉受累占72%,有症状者占67%。
- 有症状者更年轻(56 vs. 71岁,P=0.020),白细胞计数更高(12 vs. 7.6,P=0.016)。
- 壁内血肿在有症状者中更常见(58% vs. 15%,P=0.017)。
- 所有手术患者均为有症状者(42% vs. 0%,P=0.007),23%表现为急性肠系膜缺血。
- 3年生存率两组相近(无症状92.3±7.4%,有症状92.2±8.4%,P=0.696);有症状者中15%因治疗失败需二次干预。
关键数值与推荐
- 治疗策略包括观察15%、药物治疗54%、腔内手术2.6%、开放手术28%。
- 有症状者中58%无需手术干预。
临床怎么用
- 无症状病例可安全采用观察或药物治疗。
- 有症状但无急性肠系膜缺血、破裂或血流动力学不稳定证据者可选择非手术治疗。
- 应依据临床表现和影像学严重程度(如Zerbib分型、壁内血肿)制定个体化方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isolated spontaneous mesenteric artery dissections present with a broad spectrum of symptoms and are increasingly detected due to the widespread use of computed tomography. Treatment options are debated, from observation and medical management to endovascular procedures and open surgery. METHODS: A retrospective review was performed on patients with isolated superior mesenteric artery (SMA) or celiac artery dissections at a single institution from January 2017 to August 2025. Patients with concomitant aortic dissection were excluded. Data collected included clinical characteristics, imaging findings classified by Zerbib classification, treatment approaches, and outcomes. Patients were categorized based on presentation (asymptomatic versus symptomatic). RESULTS: A total of 39 patients were identified, with a median age of 58 years (interquartile range 52-71). The majority were male (87%) and Asian (62%). SMA was involved in 72% of cases, and 67% were symptomatic. Management strategies included observation (15%), medical therapy (54%), endovascular procedures (2.6%), and surgery (28%). Symptomatic patients tended to be younger (56 vs. 71 years, P = 0.020) and had higher white blood cell counts (12 vs. 7.6, P = 0.016). Intramural hematoma was more common among symptomatic patients (58% vs. 15%, P = 0.017). All patients who underwent surgery were symptomatic (42% vs. 0%, P = 0.007), and 23% presented with acute mesenteric ischemia. Among symptomatic patients, 58% did not require operative intervention, supporting nonoperative management in appropriately selected patients without evidence of acute mesenteric ischemia, rupture, or hemodynamic instability. Only 1 patient had an underlying connective tissue disorder, and one had rheumatoid arthritis with vasculitis. Three-year survival rates were comparable between groups (asymptomatic 92.3 ± 7.4%, symptomatic 92.2 ± 8.4%, P = 0.696). Symptom resolution occurred in all cases. Treatment failure requiring secondary intervention was observed in 15% of symptomatic patients. Zerbib types V and VI were associated with the need for operative intervention. CONCLUSION: Mid-term outcomes are generally favorable for both asymptomatic and symptomatic isolated mesenteric dissections. Asymptomatic cases can be managed safely with observation or medical therapy. Factors such as symptoms, Zerbib classification (V-VI), and the presence of intramural hematoma are strongly associated with the likelihood of requiring surgical intervention. Personalized management based on clinical presentation and imaging severity is essential for optimal outcomes.
引用
- Sarad N, Pizano A, Kim A, et al. Mid-Term Outcomes of Asymptomatic and Symptomatic Isolated Mesenteric Artery Dissections. Ann Vasc Surg. 2026. PMID: 42800668. doi:10.1016/j.avsg.2026.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。